K Number
K221315

Validate with FDA (Live)

Date Cleared
2023-10-25

(537 days)

Product Code
Regulation Number
872.3640
Panel
Dental
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The UNIdental Symphony Implant System is indicated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including cemented retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. The UNIdental Symphony Implant System is for single and two stage surgical procedures. It is intended for delayed loading.

Device Description

The UNIdental Symphony Implant System is a dental implant system made of Titanium 6AL 4V ELI alloy and CP Ti Grade 4 intended to be surgically placed in the bone of the upper or lower jaw arches for loading after a conventional healing period. The implants may be used to replace one or more missing teeth. The systems are similar to other commercially available products based on the intended use, the technology used, the claims, the material composition employed and performance characteristics. Symphony 1 Fixture is Bone level, and Symphony 2 Fixture is Tissue level.

Symphony 1 Fixture is a taper shape that gradually decreases the outer diameter of the lower part from the upper part.

And It is a taper shape that gradually decreases the outer diameter of the lower part from the upper part. It is a structure that can perform a tapping function at the same time without a separate tap. It couples up with the abutment and its hexagon shape.

Symphony 2 Fixture is a structure with a round shape at the end. It couples up with the abutment and its octagon shape. The area that touches the patient's gums is pure titanium surface.

The upper structure of the abutments support prosthetics such as artificial teeth to restore patient's total mouth function.

AI/ML Overview

The provided text details the 510(k) summary for the UNIdental Symphony Implant System, focusing on its substantial equivalence to predicate devices rather than directly presenting acceptance criteria and performance data in the traditional sense of a clinical study for an AI/CADe device.

This document describes a dental implant system, which is a physical medical device, not a software or AI-driven diagnostic device. Therefore, the questions related to "AI vs without AI assistance," "standalone algorithm performance," "number of experts for ground truth," "adjudication methods," and "training/test set size and provenance" are not applicable to this type of medical device submission.

The "acceptance criteria" for a dental implant system of this nature typically revolve around meeting established engineering standards and demonstrating comparable performance (e.g., mechanical strength, biocompatibility, sterilization efficacy) to already cleared predicate devices. The "study that proves the device meets the acceptance criteria" refers to the non-clinical testing performed to demonstrate substantial equivalence.

Here's an interpretation of the provided information based on the typical requirements for a physical medical device:

1. A table of acceptance criteria and the reported device performance:

The document doesn't explicitly list "acceptance criteria" in a numerical table format for each performance metric, as one might see for an AI device's sensitivity/specificity. Instead, the acceptance is implicitly demonstrated by showing substantial equivalence to existing predicate devices through various non-clinical tests and material comparisons. The "performance" is implicitly deemed acceptable if it meets the established standards that the predicates have also met.

Acceptance Criteria (Implied)Reported Device Performance (Demonstrated by Substantial Equivalence and Non-Clinical Testing)
Intended Use EquivalenceMatches the intended use of predicate devices (partially or fully edentulous mandibles and maxillae, supporting single/multi-unit restorations).
Technological Characteristics EquivalenceUses similar designs, operating principles, materials (Titanium 6AL 4V ELI alloy and CP Ti Grade 4), and sterilization methods (Gamma, Steam).
BiocompatibilityBiocompatibility tests performed per ISO 10993-3, 5, 6, 10, and 11, indicating device is biocompatible.
Sterilization EfficacySterilization validating testing performed per ISO 11137 (gamma) and ISO 17665-1/17665-2 (steam), demonstrating effective sterilization.
Mechanical Strength/FatigueCompressive load and fatigue tests performed in accordance with ISO 14801, demonstrating mechanical integrity comparable to predicate devices. The text explicitly states, "We have conducted a fatigue test and the subject device is substantially equivalent to the predicate device."
Shelf-life StabilityShelf-life testing performed in accordance with ASTM F1980, ISO 11607, ASTM F88, ASTM F1140, ASTM F1929, ASTM F2096, and ISO 11737-2, indicating stable performance over time.
Surface CharacteristicsSEM and EDS performed to evaluate fixture surface characteristics after SLA treatment. (Implied acceptability of surface given no issues raised).
Bacterial Endotoxin Levels (LAL)LAL tests performed in accordance with USP 85. (Implied acceptable levels given no issues raised).
MRI SafetyNon-clinical worst-case MRI review performed based on existing literature (e.g., Kim et al. 2019, Woods et al. 2019) and alignment with FDA guidance, concluding safety in MRI environment due to material properties.

2. Sample sized used for the test set and the data provenance:

  • Sample Size for Test Set: Not explicitly stated as a "test set" in the context of an AI model. For the non-clinical physical testing (fatigue, biocompatibility, sterilization, etc.), the sample sizes would be determined by the specific ISO/ASTM standards referenced. These standards usually specify the number of samples required for robust statistical analysis to demonstrate compliance. This is not a "data provenance" like for AI models, but rather the laboratory conditions under which the physical tests were conducted. The document doesn't specify the country of origin for the non-clinical testing data, but the submitter is UNIdental Co., Ltd. in Korea. This is inherently a prospective testing process for the device being submitted.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

  • Not Applicable. This is a physical dental implant, not a diagnostic AI device requiring expert consensus for ground truth.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

  • Not Applicable. See point 3.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

  • Not Applicable. This is a physical dental implant, not an AI-assisted diagnostic device.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

  • Not Applicable. This is a physical dental implant, not an algorithm.

7. The type of ground truth used:

  • For physical devices, "ground truth" is established through adherence to recognized national and international consensus standards (e.g., ISO, ASTM) for material properties testing, mechanical performance, biocompatibility, and sterilization. For example, the "ground truth" for fatigue resistance is meeting the load cycles and fracture limits defined by ISO 14801. Biocompatibility "ground truth" is meeting the criteria of ISO 10993 series.

8. The sample size for the training set:

  • Not Applicable. This is a physical device submission; there is no "training set" in the context of an AI model.

9. How the ground truth for the training set was established:

  • Not Applicable. See point 8.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.

October 25, 2023

UNIdental Co., Ltd. % Priscilla Chung Regulatory Affairs Consultant LK Consulting Group USA, Inc. 18881 Von Karman Ave. STE 160 Irvine. California 92612

Re: K221315

Trade/Device Name: UNIdental Symphony Implant System Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Dental Implant Regulatory Class: Class II Product Code: DZE, NHA Dated: September 29, 2023 Received: October 2, 2023

Dear Priscilla Chung:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Sherrill Lathrop Blitzer

for Andrew Steen Assistant Director

{2}------------------------------------------------

DHT1B: Division of Dental and ENT Devices OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Indications for Use

510(k) Number (if known)

K221315

Device Name UNIdental Symphony Implant System

Indications for Use (Describe)

The UNIdental Symphony Implant System is indicated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including cemented retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. The UNIdental Symphony Implant System is for single and two stage surgical procedures. It is intended for delayed loading.

Type of Use (Select one or both, as applicable)

☑ Prescription Use (Part 21 CFR 801 Subpart D)
☐ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{4}------------------------------------------------

510(k) Summary (K221315)

This summary of 510(K) information is being submitted in accordance with requirements of 21 CFR Part 807.92.

Date: 10/19/2023

1. Submitter

UNIdental Co., Ltd. #D-613 GM Techno-park, 60 Haan-ro, Gwangmyeong-si, Gyeonggi-do, 14322, Korea

Tel: +82-2-898-8715 Fax: +82-2-897-8715

2. U.S Agent/Contact Person

Priscilla Chung LK Consulting Group USA, Inc. 18881 Von Karman STE 160, Irvine CA 92612 Fax: 714-409-3357 Phone: 714-202-5789 Email: juhee.c(@lkconsultinggroup.com

3. Device

  • Trade Name: UNIdental Symphony Implant System ●
  • Common Name: Dental Implant System
  • Classification Name: Endosseous Dental Implant
  • . Primary Product Code: DZE
  • Secondary Product Code: NHA
  • Classification regulation: 21CFR 872.3640

4. Predicate Device:

  • Primary Predicate Device: ● SuperLine by Dentium Co., Ltd. (K160965)
  • Reference Predicate Device: ● ITI Dental Implant System by Straumann (K031055) Straumann TLX Implant System by Straumann USA, LLC (K200586) SuperLine by Dentium Co., Ltd. (K213599) DentiumImplantium® &SuperLine® Prosthetics by Dentium Co., Ltd. (K172640)

{5}------------------------------------------------

Multi-unit Abutment Plus by NOBEL BIOCARE AB (K161416) IMPLANTIUM ABUTMENTS by DENTIUM, INC. (K052823)

5. Description:

The UNIdental Symphony Implant System is a dental implant system made of Titanium 6AL 4V ELI alloy and CP Ti Grade 4 intended to be surgically placed in the bone of the upper or lower jaw arches for loading after a conventional healing period. The implants may be used to replace one or more missing teeth. The systems are similar to other commercially available products based on the intended use, the technology used, the claims, the material composition employed and performance characteristics. Symphony 1 Fixture is Bone level, and Symphony 2 Fixture is Tissue level.

Symphony 1 Fixture is a taper shape that gradually decreases the outer diameter of the lower part from the upper part.

And It is a taper shape that gradually decreases the outer diameter of the lower part from the upper part. It is a structure that can perform a tapping function at the same time without a separate tap. It couples up with the abutment and its hexagon shape.

Symphony 2 Fixture is a structure with a round shape at the end. It couples up with the abutment and its octagon shape. The area that touches the patient's gums is pure titanium surface.

Implant DiameterSymphony 1 Fixture3.6, 4.0, 4.5, 5.0, 5.8mm
Symphony 2 Fixture3.3, 4.1, 4.8mm
Implant LengthSymphony 1 Fixture7.0, 8.0, 10, 11.6, 12, 14mm
Symphony 2 Fixture9.35, 10.35, 12.35, 14.35, 15.35, 16.35, 17.35mm

The upper structure of the abutments support prosthetics such as artificial teeth to restore patient's total mouth function.

TypeDescriptionRawMaterialDiameterLength
HealingAbutmentSymphony 1The healing abutments provide theframework forsoft tissue healingand stability, which can achievethe formation of anidealemergence profile, prevent softTi-6Al-4V ELI4.1, 4.5,5.0, 5.5,6.5, 7.5,8.5,9.5mm9.5, 11, 12.5,14.5mm
Symphony 2tissuefrom overgrowing over theimplant fixture, and minimize thepossibility of a second surgery.Ti-6Al-4V ELI5.5,7.2mm6.5,7.5, 9,10.5, 12.5mm
StraightAbutmentSymphony 1(DualAbutment)It is a general straight typesuperstructure.The dual abutment has the shapeof an inner crown and is anabutment fixed with cement.Ti-6Al-4V ELI4.5, 5.5,6.5mm8.2, 9.2, 9.7,10.7, 11.2,11.7, 12.2,12.7, 13.2,13.7, 14.2mm

510(k) summary

{6}------------------------------------------------

The cemented abutment has the15.2mm
AngledAbutmentSymphony 2(CementedAbutment)shape of an innercrown and is anabutment that fixes the prosthesiswith dental cement, and the fixtureand connection part are hex.Ti-6Al-4V ELI3.5, 3.55,4.3mm6.7, 8.2,8.4mm
Symphony 1It is used in case of the slope ofthe prosthesis where the upperpart is not applicable.TiN coating has been applied tosome items to prevent the metalcolor from appearing black on thegums.Ti-6Al-4V ELI(TiNCoating)4.5,5.5mm12.76, 12.89,13.01, 13.30,13.79, 13.89,14.01, 14.30,14.79, 14.89,15.01,15.30mm
Symphony 2Angled Abutment combined withthe Symphony 2 fixture has A typeand B type, and the onlydifference between the two typesis the direction when fastening.The allowed angulations are 15°and 25°.Ti-6Al-4V ELI3.5,4.3mm5.5, 6.5mm
Multi-unit StraightAbutmentThis product is intended to beused by edentulous patients in theOverdenture case.Ti-6Al-4V ELI4.8mm8.2, 9.2, 9.3,10.3, 11.3,12.3mm

6. Indication for use:

The UNIdental Symphony Implant System is indicated for use in partially or fully edentulous mandibles and maxillae, in support of single or multiple-unit restorations including cemented retained, screw retained, or overdenture restorations, and terminal or intermediate abutment support for fixed bridgework. The UNIdental Symphony Implant System is for single and two stage surgical procedures. It is intended for delayed loading.

{7}------------------------------------------------

7. Basis for Substantial Equivalence

7.1 Fixture

Subject DevicePredicate DevicePredicate DevicePredicate DevicePredicate Device
DeviceNameUNIdentalSymphony ImplantSystemSuperLineITI Dental ImplantSystemStraumann TLXImplantSystemSuperLine
510(k) #K221315K160965K031055K200586K213599
ProductCodeDZE, NHADZEDZEDZE, NHADZE
ManufacturerUNIdentalCo.,LtdDENTIUM CO., LTD.StraumannStraumann USA,LLC (on behalf ofInstitut StraumannAG)DENTIUM CO.,LTD.
Indicationsfor UseThe UNIdentalSymphony ImplantSystem is indicatedfor use in partially orfully edentulousmandibles andmaxillae, in supportof single or multiple-unit restorationsincluding cementedretained, screwretained, oroverdenturerestorations, andterminal orintermediateabutment support forfixed bridgework.The UNIdentalSuperLine is indicatedfor use in surgical andrestorative applicationsfor placement in thebone of the upper orlower jaw to providesupport for prostheticdevices, such asartificial teeth, in orderto restore the patient'schewing function.SuperLine is indicatedalso for immediateloading when goodprimary stability isachieved and withappropriate occlusalloading.ITI implants areintended for surgicalplacement in maxillaryand/or mandibulararches to providesupport for prostheticin edentulous orpartially edentulouspatients. The ITIDental Implants are forsingle-stage or two-stage surgicalprocedures.Straumann TLXImplantsare suitableforendostealimplantationin the upperand lowerjaws and forthefunctional andestheticoral rehabilitationofedentulousandpartiallyedentulouspatients. TLXImplantscan be placedwithimmediatefunction onsingle-tooth and multi-unitrestorations whengoodprimary stabilityisachieved andwithappropriateocclusalloading torestorechewingfunction.SuperLine@ implantsare indicated for usein surgical andrestorativeapplications forplacement in the boneof the upper or lowerjaw to providesupport for prostheticdevices, such asartificial teeth, inorder to restore thepatient's chewingfunction. SuperLine@implants are indicatedalso for immediateloading when goodprimary stability isachieved and withappropriate occlusalloading.
and two stagesurgical procedures.It is intended fordelayed loading.Theprostheticrestorationsareconnected to theimplantsthroughthecorrespondingabutmentomponents.implants are indicatedfor delayed loading.
ImplantDesignSymphony 1FixtureImage: Symphony 1 FixtureSymphony 2 FixtureImage: Symphony 2 FixtureSuperLine FixtureImage: SuperLine FixtureCollar TypeImage: Collar TypeStraumann® TLXSPImplantImage: Straumann® TLXSP ImplantSuperLine FXSxxxxSerieImage: SuperLine FXSxxxx Serie
ImplantDiameterSymphony1Fixture3.6 – 7.0mmSymphony2Fixture3.3–4.8mm3.6 – 7.0 mm3.3 – 5.37 mmØ3.75, 4.0, 4.5, 5.0,5.5,and 6.5 mm3.6/3.6; 4.0/4.0;4.5/4.5; 5.0/5.0;5.0/6.0; 5.8/7.0 mm
Symphony1Fixture7.0 – 14.0mmSymphony2Fixture9.35-17.35mm8.0 - 14.0 mm8.0 – 16.0 mmØ3.75, 4.0, 4.5, 5.0mm:6, 8, 10, 12, 14,16 and18 mmØ5.5 and 6.5 mm:6,8, 10, 12 mmEach in 7 mm lengthonly
ImplantLength
ImplantMaterialFixture :TitaniumGrade 4ASTM F 67Ti-6Al-4V ELIASTM F136Ti-6Al-4V ELIASTM F136Titanium-13Zirconium alloy(Roxolid®)All implants:unalloyed titanium,ASTM F67
ImplantCoatingNon-coatedNon-coatedNon-coatedNon-coatedNon-coated

510(k) summary

Page

{8}------------------------------------------------

510(k) summary

Page

{9}------------------------------------------------

SurfaceTreatmentSLA TreatmentRBM(Calcium-Phosphate Media)RBM(Calcium-Phosphate Media)HydrophilicSLAactive®All implants: S.L.A.,Al2O3 blasted andacid etched
ImplantSurfaceFinishAluminum oxide>99%Sodium oxide<0.6%Iron (III) oxide< 0.2%Silicon dioxide< 0.1%Calcium Phosphate :Ha: >65%Beta-TCP :<25%Alpha-TCF :<5%TTCP: <5%Other CaP :<5%Calcium Phosphate :Ha: > 65%Beta-TCP :<25%Alpha-TCF :<5%TTCP: <5%Other CaP :<5%--
SterilizationGamma SterilizationRadiation sterilizationRadiation sterilizationRadiation sterilizationGamma Sterilization

The subject device is substantially equivalent to to SuperLine (K160965) by Dentium Co., Ltd.

They have the same indications for use and uses the same materials. The wording of the indications for use statement might be different but that of the subject device does not indications. It is written to elaborate on the indications more clearly.

The design is very similar, yet they may have some minor differences in design which does not raise a question in safety or performance. We have conducted a fatigue test and the subject device is substantially equivalent to the to the predicate device.

We identified references devices which compass the size range of the subject device.

{10}------------------------------------------------

7.2. Abutments

Subject DevicePredicate Device
Device Name:UNIdental Symphony Implant SystemDentium Implantium® &SuperLine® Prosthetics
510(k) #K221315K172640
ManufacturerUNIdental Co.,Ltd.Dentium Co., Ltd.
Product CodeDZE, NHANHA
Healing Abutments
Symphony 1Symphony 2
DesignImage: Symphony 1 Healing AbutmentImage: Symphony 2 Healing AbutmentImage: Predicate Device Healing Abutment
Abutment MaterialsTi 6Al 4V ELI,Gr.23Ti 6Al 4V ELI, Gr.23Ti 6Al 4V ELI, Gr.23
Intended UseTo help the softtissue of gumnaturally formedTo help the soft tissueof gum naturallyformedTo help the soft tissue of gumnaturally formed.
Diameterpost heights4.1~9.5mm5.5~7.2mm4.0~9.5mm
gingival collar heights2.0~7.0mm2.0~7.0mm2.0~7.0mm
2~4mm2~4mm2~4mm
Surface TreatmentNoNoNo
SterilizationSteam Sterilizationby userSteam Sterilizationby userSteam Sterilization by user
Angled Abutment
Symphony 1Symphony 2
Design & Size RangeImage: Symphony 1 Angled AbutmentAngle : 15, 25(Internal hex)Image: Symphony 2 Angled AbutmentAngle : 15, 20(Internal octa)Image: Angled AbutmentAngle : 15, 25
Abutment MaterialsTi 6Al 4V ELI,Gr.23Ti 6Al 4V ELI, Gr.23Ti 6Al 4V ELI, Gr.23
Intended UseStructure ofabutmentlift the prosthesisStructure of abutmentLift the prosthesisStructure of abutmentLift the prosthesis
Diameter4.5~5.5mm3.5~4.3mm4.5~5.5mm
gingival collar heightsangulations1.5~3.5mmAngle : 15, 251.5~3.5mmAngle : 15, 201.5~3.5mmAngle : 15, 25
Surface TreatmentTiN coating - Goldcolor (Partly)NoNo
SterilizationSteam Sterilizationby userSteam Sterilization byuserSteam Sterilization by user

{11}------------------------------------------------

Dual Abutment
Design & Size RangeImage: Dual Abutment (Internal hex)Image: Dual Abutment
Abutment MaterialsTi 6Al 4V ELI,Gr.23CP Ti Gr.4
Intended UseCement retainedrestorationCement retained restoration
Diameter4.5~6.5mm4.5~6.5mm
gingival collar heights1.0~5.5mm1.0~5.5mm
Surface TreatmentTiN coating - Goldcolor (Partly)TiN coating - Gold color (Partly)
SterilizationSteam Sterilizationby userSteam Sterilization by user

The subject device is substantially equivalent to SuperLine (K160965) by Dentium Co., Ltd. They have the same indications for use and uses the same materials. The design is very similar, yet they may have some minor differences in design and dimension which does not raise a question in safety or performance. We have conducted a fatigue test and the results support that the subject device is substantially equivalent to the predicate device.

Subject DevicePredicate Device
Device Name:UNIdental Symphony Implant SystemStraumann TLX ImplantSystem
510(k) #K221315K200586
ManufacturerUNIdentalCo.,LtdDZE, NHA
Product CodeDZE, NHAStraumann USA, LLC (on behalf ofInstitut Straumann AG)
Design & Size RangeImage: Cemented Abutment (Internal screw retained)Image: Abutments
Abutment MaterialsTi 6Al 4V ELI, Gr.23Titanium alloy
Intended UseCement retained restorationCement retained restoration
Diameter3.55~4.3mm3.5~5mm
post heights5.5mm5.7mm, 6mm
angulationsAngle : 0Angle : 0, 15
Surface TreatmentNoNo
SterilizationSteam Sterilization by userSteam Sterilization by user

The subject device is substantially equivalent to to Straumann TLX ImplantSystem (K200586) by Straumann USA.

They have the same indications for use and uses the same materials. The design is very similar, yet they may have some minor differences in design which does not raise a question in safety or performance.

  • Multi-unit Straight Abutment

510(k) summary

{12}------------------------------------------------

Subject DevicePredicate Device
Device Name:UNIdental Symphony Implant SystemMulti-unit Abutment Plus
510(k) #K221315K161416
ManufacturerUNIdentalCo.,LtdNOBEL BIOCARE AB
Product CodeDZE, NHANHA
Symphony 1Symphony 2
Design & Size RangeImage: Symphony 1Image: Symphony 2Image: Multi-unit Abutment Plus
Abutment MaterialsTi 6Al 4V ELI,Gr.23Ti 6Al 4V ELI,Gr.23Titanium vanadium alloy
Intended UseStructure ofabutmentlift the prosthesisStructure ofabutmentlift the prosthesisStructure of abutmentlift the prosthesis
Diameter4.8mm4.8mm4.8mm
gingival collar heights1.0~5.0mm1.0~5.0mm1.5~4.5mm
angulationsAngle : 0Angle : 0Angle : 0, 17, 30
Surface TreatmentNoNoNo
SterilizationSteam Sterilizationby userSteam Sterilizationby userSteam Sterilization by user

The subject device is substantially equivalent to Multi-unit Abutment Plus (K161416) by NOBEL BIOCARE AB.

They have the same indications for use and uses the same materials. The design is very similar, yet they may have some minor differences in design which does not raise a question in safety or performance.

7. 3. Screws

Subject DevicePredicate Device
510(K) NumberUNIdental Symphony Implant SystemIMPLANTIUM ABUTMENTS
Device NameK221315K052823
ManufacturerDZE, NHADENTIUM, INC.
Product CodeUNIdental Co.,Ltd.NHA
Cover Screw
Symphony 1Symphony 2
DesignImage: Symphony 1Image: Symphony 2Image: Predicate Device
Intended UseTo provide sealingeffect for fixtureTo provide sealingeffect for fixtureTo provide sealing effect for fixture

{13}------------------------------------------------

Diameter3.6~6.0mm3.6~6.0mm3.8~5.8mm
Material CompositionTi 6A1 4V ELI,Gr.23Ti 6A1 4V ELI,Gr.23Ti 6Al 4V ELI, Gr.23
Surface TreatmentNoNoAnodizing coloring(Entire Body)
SterileSteam Sterilizationby userSteam Sterilizationby userRadiation sterilization
Abutment Screw
Symphony 1Symphony 2
DesignImage: Abutment Screw Symphony 1Image: Abutment Screw Symphony 2Image: Abutment Screw
Intended UseTo connect theabutment to thefixtureTo connect theabutment to thefixtureTo connect the abutment to the fixture
Diameter2.0~2.4mm2.0~2.4mm2.3mm
Material CompositionTi-6Al-4V ELIASTM F136Ti-6Al-4V ELIASTM F136Ti-6Al-4V ELIASTM F136
Surface TreatmentNoNoNo
SterileSteam Sterilizationby userSteam Sterilizationby userSteam Sterilization by user

The subject device is substantially equivalent to toSuperLine (K160965) by Dentium Co., Ltd. They have the same indications for use and uses the same materials. The design is very similar, yet they may have some minor differences in design which does not raise a question in safety or performance. We have conducted a fatigue test and the results support that the subject device is substantially equivalent to the predicate device.

8. Non-Clinical Testing

  • . Sterilization validating testing has been performed in accordance with ISO 11137 for gamma sterilization and ISO 17665-1 and ISO 17665-2 for steam sterilization.
  • . Shelf-life testing has been performed in according with ASTM F1980, ISO 11607, ASTM F88, ASTM F1140, ASTM F1929, ASTM F2096 and ISO 11737-2.
  • . SEM (Scanning Electron Microscope) and EDS(Energy-dispersive X-ray spectroscopy) were performed to evaluate the fixture surface characteristics after SLA treatment.
  • . Biocompatibility Tests were performed in accordance with ISO 10993-3, 5, 6, 10, and 11.
  • Compressive load and fatigue tests in accordance with ISO 14801
  • Bacterial Endotoxin Levels (LAL) in accordance with USP 85
  • . MRI Safety
    • A non-clinical worst-case MRI review was conducted to evaluate the UNIdental

{14}------------------------------------------------

Symphony Implant System in an MRI environment. Various dental journals were utilized to ensure its stability, and scientific evidence from literature was considered. such as the study by Yong-Ha Kim, Manki Choi, and Jae-Won Kim titled 'Are titanium implants actually safe for magnetic resonance imaging examinations?' (Arch Plast Surg 2019;46:96-97). The study concluded that titanium, being a paramagnetic material, is not affected by the magnetic field of MRI. The risk of implant-based complications is very low, and MRI can be safely used in patients with implants. Based on this paper, the stability of the raw material of the UNIdental Symphony Implant System in an MRI environment was confirmed.

In the study conducted by Woods, Terry O., Jana G. Delfino, and Sunder Rajan titled 'Assessment of Magnetically Induced Displacement Force and Torque on Metal Alloys Used in Medical Devices' (Journal of Testing and Evaluation 49.2 (2019): 783-795). Titanium Grade 4 was evaluated using magnetic induction displacement force (ASTM F2052), magnetic induction torque (ASTM F2213), RF induction heating (ASTM F2182), and image artifact (ASTM F2119) tests by T. O. Woods et al. Based on this research, we have addressed parameters per FDA guidance "Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment".

9. Conclusion

The subject devices and the predicate device have the same intended use and have the same technological characteristics.

Overall, the UNIdental Symphony Implant System has the following similarities to the predicate device:

    • have the same intended use,
    • use the same operating principle,
    • incorporate similar design,
    • incorporate the same material and the sterilization method

Based on the similarities, we conclude that the UNIdental Symphony Implant System is substantially equivalent to the predicate devices.

§ 872.3640 Endosseous dental implant.

(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.